Saving orphans: BRAF targeting of histiocytosis. A patient with Langerhans cell histiocytosis in the skin (top panels) and Erdheim-Chester disease in the long bones (bottom panels) before and after treatment with vemurafenib.1 Professional illustration by Alice Y. Chen.
